Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Stock Short Interest Report for September

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 65 shares, a growth of 170.8% from the September 15th total of 24 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 1,647 shares, the days-to-cover ratio is presently 0.0 days.

Innovator IBD Breakout Opportunities ETF Stock Performance

BOUT traded down $0.11 during trading hours on Monday, reaching $43.06. The company’s stock had a trading volume of 366 shares, compared to its average volume of 3,523. Innovator IBD Breakout Opportunities ETF has a 52 week low of $35.05 and a 52 week high of $49.41. The company’s 50-day moving average is $44.20 and its 200-day moving average is $44.94. The firm has a market cap of $15.07 million, a PE ratio of 28.69 and a beta of 1.04.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.